Acquisitions30 Jul 2025, 08:07 pm
Orchid Pharma Acquires Weilchensee 1272. V V GmbH for Euro 28500
AI Summary
Orchid Pharma Ltd has acquired 100% share capital of Weilchensee 1272. V V GmbH, a company incorporated under the laws of Germany. The acquisition, now named Orchid Pharma Europe GmbH, was made for a cash consideration of Euro 28500. This acquisition aims to expand Orchid Pharma's market reach in Europe. The acquired company, a shelf company registered in Germany, was incorporated on June 24, 2025, and does not have any prior line of business or turnover history.
Key Highlights
- Orchid Pharma has acquired Weilchensee 1272. V V GmbH for Euro 28500
- The acquired company will be renamed Orchid Pharma Europe GmbH
- The acquisition aims to expand Orchid Pharma's market reach in Europe
- The acquired company was a shelf company registered in Germany with no prior line of business or turnover history
- The acquisition was made for a cash consideration